Windtree Faces Delisting as Nasdaq Tightens its Rules

Nasdaq plans to delist Windtree Therapeutics for violating minimum bid price rules. Windtree struggles with financial instability, possibly linked to its BNB investments. Continue Reading: Windtree Faces Delisting as Nasdaq Tightens its Rules The post Windtree Faces Delisting as Nasdaq Tightens its Rules appeared first on COINTURK NEWS .